The role of thermalablation in treatment of vaginal discharge

Role of thermal ablation in the management of symptomatic cervical ectropion. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/087641

Enrollment

Registered

2025-05-26

Start date

Unknown

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N888- Other specified noninflammatory disorders of cervix uteri

Interventions

Intervention1: THERMAL ABLATION: Thermalablation will be performed using a hand-held device , WISAP thermal ablator.the tip of probe will be placed in contact with area of ectropion for 40 secs. Inte

Eligibility

Inclusion criteria

Inclusion criteria: Multiparous Cervical ectropion on per speculum examination Persistent or recurrent vaginal discharge Normal cervical cancer screening test Normal or inflammatory cervical cytology Willing to participate

Exclusion criteria

Exclusion criteria: Unmarried Nulliparous women Postmenopausal women Abnormal screening test (cytology or hr-HPV DNA) Previous cervical ablation procedure or loop electrosurgical excision procedure LEEP Past history of CIN Immunocompromised Immunosuppressant Pregnancy or Lactation Warts/ any other acute vulvovaginal infection Distorted shape of cervix due to old tears

Design outcomes

Primary

Measure	Time frame
Proportion of patients reporting symptomatic relief Change in symptom assessed through visual analog scale Timepoint: assessed at 6wks and 3months.	—

Secondary

Measure	Time frame
adverse effect time taken for resolution of symptoms patient satisfaction Timepoint: 6wks & 3months	—

Countries

India

Contacts

Public ContactDr Avantika Raina

PGIMER chandigarh

drrimpisingla@gmail.com7087008008

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026